Intravascular malignant lymphomatosis: Amelioration of neurological symptoms with plasmapheresis

Cheryl P. Harris, June D. Sigman, Kurt A. Jaeckle

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Intravascular malignant lymphomatosis is a rare disease that is uniformly fatal when disseminated. Chemotherapeutic and radiation therapy regimens have provided short-term amelioration of symptoms but have not affected overall survival. We describe a patient with diffuse neurological symptoms who responded transiently but dramatically to plasmapheresis. This marked response warrants further evaluation of this therapy in intravascular malignant lymphomatosis.

Original languageEnglish (US)
Pages (from-to)357-359
Number of pages3
JournalAnnals of Neurology
Volume35
Issue number3
StatePublished - Mar 1994
Externally publishedYes

Fingerprint

Plasmapheresis
Rare Diseases
Radiotherapy
Survival
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Intravascular malignant lymphomatosis : Amelioration of neurological symptoms with plasmapheresis. / Harris, Cheryl P.; Sigman, June D.; Jaeckle, Kurt A.

In: Annals of Neurology, Vol. 35, No. 3, 03.1994, p. 357-359.

Research output: Contribution to journalArticle

Harris, CP, Sigman, JD & Jaeckle, KA 1994, 'Intravascular malignant lymphomatosis: Amelioration of neurological symptoms with plasmapheresis', Annals of Neurology, vol. 35, no. 3, pp. 357-359.
Harris, Cheryl P. ; Sigman, June D. ; Jaeckle, Kurt A. / Intravascular malignant lymphomatosis : Amelioration of neurological symptoms with plasmapheresis. In: Annals of Neurology. 1994 ; Vol. 35, No. 3. pp. 357-359.
@article{7d12e030fcf6494d999851c39f5d7bcc,
title = "Intravascular malignant lymphomatosis: Amelioration of neurological symptoms with plasmapheresis",
abstract = "Intravascular malignant lymphomatosis is a rare disease that is uniformly fatal when disseminated. Chemotherapeutic and radiation therapy regimens have provided short-term amelioration of symptoms but have not affected overall survival. We describe a patient with diffuse neurological symptoms who responded transiently but dramatically to plasmapheresis. This marked response warrants further evaluation of this therapy in intravascular malignant lymphomatosis.",
author = "Harris, {Cheryl P.} and Sigman, {June D.} and Jaeckle, {Kurt A.}",
year = "1994",
month = "3",
language = "English (US)",
volume = "35",
pages = "357--359",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Intravascular malignant lymphomatosis

T2 - Amelioration of neurological symptoms with plasmapheresis

AU - Harris, Cheryl P.

AU - Sigman, June D.

AU - Jaeckle, Kurt A.

PY - 1994/3

Y1 - 1994/3

N2 - Intravascular malignant lymphomatosis is a rare disease that is uniformly fatal when disseminated. Chemotherapeutic and radiation therapy regimens have provided short-term amelioration of symptoms but have not affected overall survival. We describe a patient with diffuse neurological symptoms who responded transiently but dramatically to plasmapheresis. This marked response warrants further evaluation of this therapy in intravascular malignant lymphomatosis.

AB - Intravascular malignant lymphomatosis is a rare disease that is uniformly fatal when disseminated. Chemotherapeutic and radiation therapy regimens have provided short-term amelioration of symptoms but have not affected overall survival. We describe a patient with diffuse neurological symptoms who responded transiently but dramatically to plasmapheresis. This marked response warrants further evaluation of this therapy in intravascular malignant lymphomatosis.

UR - http://www.scopus.com/inward/record.url?scp=0028224535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028224535&partnerID=8YFLogxK

M3 - Article

C2 - 8122888

AN - SCOPUS:0028224535

VL - 35

SP - 357

EP - 359

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 3

ER -